Hunter syndrome (MPS II) is a rare, progressive disease with no cure yet. Operation Hunter backs every credible scientific path to one — funding research, recruiting investigators, and winning grants — and prioritizes the approaches that can reach the brain, where this disease does its cruelest work.
We are the catalyst, not the clinic. Funding and assembling a trial is one path; helping extend a promising brain-reaching therapy is another. Every dollar and every conversation moves qualified teams one step closer to a win.
Back every credible scientific route to a cure — not just one. We raise money, recruit investigators, and win grants, prioritizing approaches that can cross into the brain. Funding a new trial is one path; helping extend an existing brain-reaching therapy is another — all under FDA/IRB oversight.
Donations and an equal-odds sweepstakes fund grant applications, investigator outreach, and the 501(c)(3) standing the effort up. Every claim is cited; bad news surfaces early.
We scout publicly-published MPS II researchers, screen grants for eligibility and deadlines, and draft the legal and tax structure for a licensed attorney and CPA to sign off.
Sign in to the mission console to follow progress, talk to the assistant, and track the campaign. Investigators, sponsors, and supporters — reach out through the console.